Skip to content

MinerOss XP MINXP-CAN0.5SMRecalls & reported problems

Collagen Matrix, Inc. · Porcine Anorganic Bone Mineral 0.5cc (Particle Size 0.25 - 1.0 mm) · Class 2 · Implant

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00813954021645), received between Mar 24, 2025 and Mar 24, 2025 — classified as 1 injury.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 1 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • No Apparent Adverse Event1

Patient problems

  • Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryMar 24, 2025No Apparent Adverse Event; No Apparent Adverse Event

    COLLAGEN MATRIX, INC. RECEIVED MEDWATCH FORM MW5166536-1 FROM THE FDA ON 02/17/2025. THE FORM INDICATES THAT ON (B)(6) 2024, THE PATIENT HAD AN ALLOGRAFT DONE AT AN UNKNOWN SITE/LOCATION. SINCE THEN, THE PATIENT CONTRACTED TUBERCULOSIS (TB) AND HAS BEEN WORKING WITH PHYSICIANS TO GET ON A 9-MONTH ANTIBIOTIC REGIMEN. SINCE THE LAST TIME THE PATIENT TESTED NEGATIVE FOR TB. THE ONLY OTHER PERSON THE PATIENT HAD SUBSTANTIAL CONTACT WITH HAS RECENTLY TESTED NEGATIVE FOR TB. AS A RESULT, IT IS SUSPECTED THAT THE ALLOGRAFT TO BE THE MEANS BY WHICH THE PATIENT CONTRACTED TB. IN THE INITIAL MEDWATCH FORM, THE FOLLOWING PRODUCTS WERE INDICATED AS FOLLOWS: INFORMATION ABOUT THE COMPANIES INVOLVED IN PROVIDING THE BONE TISSUE USED IN (B)(6) ALLOGRAFT: MINEROSS XP, REF: MINXPCAN0.5SM LOT PMCU23K1; USE BY 2026-08-31 MANUFACTURER: COLLAGEN MATRIX INC. DISTRIBUTED BY (B)(4) LOT: FG24030528, CORTICAL AND CANCELLOUS CHIPS 1.0CC QUALITY DEPARTMENT (B)(6). CADAVER BONE TISSUE IMPLANTED IN ALLOGRAFT. COLLAGEN MATRIX, INC. REACHED OUT TO THE INITIAL COMPLAINANT THAT OUR PRODUCT IS A XENOGRAFT (PORCINE ANORGANIC BONE MINERAL) AND NOT AN ALLOGRAFT INITIALLY INDICATED IN THE MEDWATCH FORM. ADDITIONAL INFOR

    Patient problems: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available

    MAUDE report 21677347 ↗

Other Bone Grafting Material, Animal Source devices

All Bone Grafting Material, Animal Source devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page